Biomanufacturing, Biopharmaceutical

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, announced that the University of Delaware, on behalf of NIIMBL, has entered into a Collaborative Research and Development Agreement (CRADA) with the Food and Drug Administration (FDA). Effective July 15, 2019, the FDA and NIIMBL will...

Biomanufacturing, Biopharmaceutical

“Sudhin Biopharma Company became familiar with ARMI during several networking meetings at NIIMBL and heard your CTO, Thomas Bollenbach, speak about ARMI at the conference on the “Business of Regenerative Medicine” at U Penn Medicine last summer, 2018,” said Dhinakar Kompala, Founder & CEO, adding “We discussed the benefits of joining ARMI with Tom...

Bioengineering, Biomanufacturing, Biopharmaceutical

The mission of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, is to accelerate biopharmaceutical manufacturing innovation, support the development of standards that enable more efficient and rapid manufacturing capabilities, and educate and train a world-leading biopharmaceutical...

Biomanufacturing, Biopharmaceutical

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a Manufacturing USA institute, announces a grant to help fund the advancement of biopharmaceutical manufacturing technology in the U.S. and globally from the Bill & Melinda Gates Foundation.

NIIMBL will receive up to $1.5M from the foundation to support the...